Delivery Order SPE2DR25D2101-SPE2DR26F46CM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,324.81. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal medical procurement. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a contract value of $2,637.10. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and no set-aside designation was utilized. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,685.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on a firm fixed-price basis. The contract, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $27,146.46 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on December 4, 2025, with a completion date of December 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $7,799.66. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $86,447.52 to AmerisourceBergen Drug Corp for the supply of Rifampin Capsules. This contract, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. The award represents a competitive procurement action, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $35,905.41 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count) under a firm fixed-price contract valued at $2,553.81. The award was made on September 13, 2025, with an ultimate completion date of September 15, 2025. This is a non-set-aside competitive award, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under a larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46CMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) with a contract value of $2,760.57. This competitive, non-set-aside delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilizes firm fixed-price pricing terms typical of pharmaceutical supply contracts within the federal medical procurement system. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated extensive capability in supplying medications and medical supplies to support military and veteran healthcare systems. The rifampin order fulfills pharmaceutical support needs across the defense medical supply chain, enabling the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its comprehensive contract vehicle supporting global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/1/25 |